{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:17:03Z","timestamp":1791065823067,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2003,2]]},"DOI":"10.1007\/s11916-003-0006-4","type":"journal-article","created":{"date-parts":[[2007,6,7]],"date-time":"2007-06-07T14:02:29Z","timestamp":1181224949000},"page":"24-33","source":"Crossref","is-referenced-by-count":22,"title":["Antidepressants for chronic neuropathic pain"],"prefix":"10.1007","volume":"7","author":[{"given":"Lori","family":"Reisner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"6_CR1","first-page":"233","volume":"4","author":"KR Krishnan","year":"1989","unstructured":"Krishnan KR, France RD: Antidepressants in chronic pain syndromes. Am Fam Physician 1989, 4:233\u2013237.","journal-title":"Am Fam Physician"},{"issue":"suppl 1","key":"6_CR2","first-page":"146","volume":"5","author":"R Lee","year":"1977","unstructured":"Lee R, Spencer PS: Antidepressants and pain: a review of the pharmacologic data supporting the use of certain tricyclics in chronic pain. J Int Med Res 1977, 5(suppl 1):146\u2013156.","journal-title":"J Int Med Res"},{"key":"6_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0304-3959(85)90223-4","volume":"23","author":"C Feinmann","year":"1985","unstructured":"Feinmann C: Pain relief by antidepressants: possible modes of action. Pain 1985, 23:1\u20138.","journal-title":"Pain"},{"key":"6_CR4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/00000539-200207000-00029","volume":"95","author":"F Yokogawa","year":"2002","unstructured":"Yokogawa F, Kiuchi Y, Ishikawa Y, et al.: An investigation of monoamine receptors involved in antinociceptive effects of antidepressants. Anesth Analg 2002, 95:163\u2013168.","journal-title":"Anesth Analg"},{"key":"6_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0014-2999(99)00464-1","volume":"378","author":"AM Gray","year":"1999","unstructured":"Gray AM, Pache DM, Sewell RD: Do alpha2-adrenoceptors play an integral role in the antinociceptive mechanism of action of antidepressant compounds? Eur J Pharmacol 1999, 378:161\u2013168.","journal-title":"Eur J Pharmacol"},{"key":"6_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/0014-2999(83)90556-3","volume":"90","author":"C Schmauss","year":"1983","unstructured":"Schmauss C, Hammond DL, Ochi JW, Yaksh TL: Pharmacologic antagonism of the antinociceptive effects of serotonin in the rat spinal cord. Eur J Pharmacol 1983, 90:349\u2013357.","journal-title":"Eur J Pharmacol"},{"key":"6_CR7","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1056\/NEJM199205073261904","volume":"326","author":"MB Max","year":"1992","unstructured":"Max MB, Lynch SA, Muir J, et al.: Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992, 326:1250\u20131256.","journal-title":"N Engl J Med"},{"key":"6_CR8","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1001\/jama.243.11.1147","volume":"243","author":"RW Turkington","year":"1980","unstructured":"Turkington RW: Depression masquerading as diabetic neuropathy. JAMA 1980, 243:1147\u20131150.","journal-title":"JAMA"},{"key":"6_CR9","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.37.4.589","volume":"37","author":"MB Max","year":"1987","unstructured":"Max MB, Culnane M, Schafer SC, et al.: Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987, 37:589\u2013596.","journal-title":"Neurology"},{"key":"6_CR10","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/j.1365-2044.1992.tb02383.x","volume":"47","author":"HJ McQuay","year":"1992","unstructured":"McQuay HJ, Carroll D, Glynn CJ: Low-dose amitriptyline in the treatment of chronic pain. Anaesthesia 1992, 47:646\u2013652.","journal-title":"Anaesthesia"},{"key":"6_CR11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0006-8993(92)91490-6","volume":"597","author":"JM Kiefel","year":"1992","unstructured":"Kiefel JM, Cooper ML, Bodnar RJ: Serotonin receptor subtype antagonists in the medial ventral medulla inhibit mesencephalic opiate analgesia. Brain Res 1992, 597:331\u2013338.","journal-title":"Brain Res"},{"key":"6_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0006-8993(87)90883-3","volume":"426","author":"JL Steinman","year":"1987","unstructured":"Steinman JL, Carlton SM, Haber B, Willis WD: Differential effects of p-chlorophenylalanine on indolamines in brainstem nuclei and spinal cord of rats I: biochemical and behavioral analysis. Brain Res 1987, 426:297\u2013309.","journal-title":"Brain Res"},{"key":"6_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0304-3959(77)90083-5","volume":"4","author":"RB Messing","year":"1977","unstructured":"Messing RB, Lytle LD: Serotonin-containing neurons: their possible role in pain and analgesia. Pain 1977, 4:1\u201321.","journal-title":"Pain"},{"key":"6_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S0304-3959(99)00154-2","volume":"83","author":"SH Sindrup","year":"1999","unstructured":"Sindrup SH, Jensen TS: Efficacy of pharmacologic treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999, 83:389\u2013400. Provides excellent mechanistic background.","journal-title":"Pain"},{"key":"6_CR15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0885-3924(97)00077-8","volume":"13","author":"D Bowsher","year":"1997","unstructured":"Bowsher D: The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, doubleblind, placebo-controlled trial. J Pain Symptom Manage 1997, 13:327\u2013331.","journal-title":"J Pain Symptom Manage"},{"key":"6_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0014-2999(02)01436-X","volume":"439","author":"JA Terron","year":"2002","unstructured":"Terron JA: Is the 5-HT(7) receptor involved in the pathogenesis and prophylactic treatment of migraine? Eur J Pharmacol 2002, 439:1\u201311.","journal-title":"Eur J Pharmacol"},{"key":"6_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0014-2999(85)90247-X","volume":"112","author":"MC de Felipe","year":"1985","unstructured":"de Felipe MC, De Ceballos ML, Gil C, Fuentes JA: Chronic antidepressant treatment increases enkephalin levels in n. accumbens and striatum of the rat. Eur J Pharmacol 1985, 112:119\u2013122.","journal-title":"Eur J Pharmacol"},{"key":"6_CR18","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/sj.bjp.0701882","volume":"124","author":"AM Gray","year":"1998","unstructured":"Gray AM, Spencer PS, Sewell RD: The involvement of the opioidergic system in the antinociceptive mechanism of action of antidepressant compounds. Br J Pharmacol 1998, 124:669\u2013674.","journal-title":"Br J Pharmacol"},{"key":"6_CR19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0304-3940(99)00627-8","volume":"273","author":"S Schreiber","year":"1999","unstructured":"Schreiber S, Backer MM, Pick CG: The antinociceptive effect of venlafaxine in mice is mediated through opioid and adrenergic mechanisms. Neurosci Lett 1999, 273:85\u201388.","journal-title":"Neurosci Lett"},{"key":"6_CR20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1385\/JMN:18:1-2:143","volume":"18","author":"S Schreiber","year":"2002","unstructured":"Schreiber S, Bleich A, Pick CG: Venlafaxine and mirtazapine: different mechanisms of antidepressant action, common opioid-mediated antinociceptive effects: a possible opioid involvement in severe depression? J Mol Neurosci 2002, 18:143\u2013149. Provides evidence that newer antidepressants exert pain-relieving benefits through a unique mechanism of action.","journal-title":"J Mol Neurosci"},{"key":"6_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0166-4328(00)00185-6","volume":"114","author":"S Schreiber","year":"2000","unstructured":"Schreiber S, Backer MM, Herman I, et al.: The antinociceptive effect of trazodone in mice is mediated through both \u03bc-opioid and serotonergic mechanisms. Behav Brain Res 2000, 114:51\u201356.","journal-title":"Behav Brain Res"},{"key":"6_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0924-977X(96)00031-4","volume":"6","author":"S Schreiber","year":"1996","unstructured":"Schreiber S, Backer MM, Yanai J, Pick CG: The antinociceptive effect of fluvoxamine. Eur Neuropsychopharmacol 1996, 6:281\u2013284.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"suppl 4","key":"6_CR23","doi-asserted-by":"publisher","first-page":"S408","DOI":"10.1016\/0304-3959(87)91872-0","volume":"66","author":"C Post","year":"1987","unstructured":"Post C, Gordh T Jr, Jansson I, et al.: Interactions between spinal noradrenergic and cholinergic mechanism of anti-nociception [abstract]. Pain 1987, 66(suppl 4):S408.","journal-title":"Pain"},{"key":"6_CR24","first-page":"201","volume":"140","author":"VK Bhargava","year":"2001","unstructured":"Bhargava VK, Saha L: Cholinergic mechanism in imipramine and morphine antinociception. Boll Chim Farm 2001, 140:201\u2013204.","journal-title":"Boll Chim Farm"},{"key":"6_CR25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2165\/00002512-199608060-00008","volume":"8","author":"HM Bryson","year":"1996","unstructured":"Bryson HM, Wilde MI: Amitriptyline: a review of its pharmacologic properties and therapeutic use in chronic pain states. Drugs Aging 1996, 8:459\u2013476.","journal-title":"Drugs Aging"},{"key":"6_CR26","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1023\/A:1015061317793","volume":"47","author":"K Bielefeldt","year":"2002","unstructured":"Bielefeldt K, Ozaki N, Whiteis C, Gebhart GF: Amitriptyline inhibits voltage-sensitive sodium currents in rat gastric sensory neurons. Dig Dis Sci 2002, 47:959\u2013966.","journal-title":"Dig Dis Sci"},{"key":"6_CR27","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1097\/00000542-200104000-00021","volume":"94","author":"P Gerner","year":"2001","unstructured":"Gerner P, Mujtaba M, Sinnott CJ, Wang GK: Amitriptyline versus bupivacaine in rat sciatic nerve blockade. Anesthesiology 2001, 94:661\u20137.","journal-title":"Anesthesiology"},{"key":"6_CR28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/00000542-200101000-00024","volume":"94","author":"ME Brau","year":"2001","unstructured":"Brau ME, Dreimann M, Olschewski A, et al.: Effect of drugs used for neuropathic pain management on tetrodotoxinresistant Na(+) currents in rat sensory neurons. Anesthesiology 2001, 94:137\u2013144.","journal-title":"Anesthesiology"},{"key":"6_CR29","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0022-3565(24)37206-4","volume":"284","author":"JJ Pancrazio","year":"1998","unstructured":"Pancrazio JJ, Kamatchi GL, Roscoe AK, Lynch C: Inhibition of neuronal Na+ channels by antidepressant drugs. J Pharmacol Exp Ther 1998, 284:208\u2013214.","journal-title":"J Pharmacol Exp Ther"},{"key":"6_CR30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0304-3940(02)00491-3","volume":"328","author":"A Ulugol","year":"2002","unstructured":"Ulugol A, Karadag HC, Tamer M, et al.: Involvement of adenosine in the anti-allodynic effect of amitriptyline in streptozotocin-induced diabetic rats. Neurosci Lett 2002, 328:129\u2013132.","journal-title":"Neurosci Lett"},{"key":"6_CR31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/jat\/14.4.217","volume":"14","author":"DN Bailey","year":"1990","unstructured":"Bailey DN: Percutaneous absorption of tricyclic antidepressants: amitriptyline, nortriptyline, imipramine, and desipramine. J Anal Toxicol 1990, 14:217\u2013218.","journal-title":"J Anal Toxicol"},{"key":"6_CR32","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0014-2999(01)01276-6","volume":"430","author":"MJ Esser","year":"2001","unstructured":"Esser MJ, Chase T, Allen GV, Sawynok J: Chronic administration of amitriptyline and caffeine in a rat model of neuropathic pain: multiple interactions. Eur J Pharmacol 2001, 430:211\u2013218.","journal-title":"Eur J Pharmacol"},{"key":"6_CR33","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/00000539-200202000-00038","volume":"94","author":"CE Heughan","year":"2002","unstructured":"Heughan CE, Allen GV, Chase TD, Sawynok J: Peripheral amitriptyline suppresses formalin-induced Fos expression in the rat spinal cord. Anesth Analg 2002, 94:427\u2013431.","journal-title":"Anesth Analg"},{"key":"6_CR34","first-page":"820","volume":"49","author":"G Kiefer","year":"1999","unstructured":"Kiefer G, Fischer W, Feuerstein TJ: Effects of amitriptyline, amitriptylinoxide, doxepine and clozapine on N-methyl-D-aspartate-evoked release of [3H]-acetylcholine in rat caudatoputamen. Arzneimittelforschung 1999, 49:820\u2013823.","journal-title":"Arzneimittelforschung"},{"key":"6_CR35","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1097\/00000542-199511000-00018","volume":"83","author":"JC Eisenach","year":"1995","unstructured":"Eisenach JC, Gebhart GF: Intrathecal amitriptyline acts as an N-methyl-D-aspartate receptor antagonist in the presence of inflammatory hyperalgesia in rats. Anesthesiology 1995, 83:1046\u20131054.","journal-title":"Anesthesiology"},{"key":"6_CR36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0014-2999(92)90579-S","volume":"219","author":"Z Cai","year":"1992","unstructured":"Cai Z, McCaslin PP: Amitriptyline, desipramine, cyproheptadine and carbamazepine, in concentrations used therapeutically, reduce kainate- and N-methyl-D-aspartate-induced intracellular Ca2+ levels in neuronal culture. Eur J Pharmacol 1992, 219:53\u201357.","journal-title":"Eur J Pharmacol"},{"key":"6_CR37","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1471-4159.1992.tb09385.x","volume":"59","author":"PP McCaslin","year":"1992","unstructured":"McCaslin PP, Yu XZ, Ho IK, Smith TG: Amitriptyline prevents N-methyl-D-aspartate (NMDA)-induced toxicity, does not prevent NMDA-induced elevations of extracellular glutamate, but augments kainate-induced elevations of glutamate. J Neurochem 1992, 59:401\u2013405.","journal-title":"J Neurochem"},{"key":"6_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00210-001-0496-8","volume":"365","author":"C Ghelardini","year":"2002","unstructured":"Ghelardini C, Galeotti N, Bartolini A: Amitriptyline and clomipramine activate Gi-protein signaling pathway in the induction of analgesia. Naunyn Schmiedebergs Arch Pharmacol 2002, 365:1\u20137.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"6_CR39","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/S0006-2952(02)00882-1","volume":"63","author":"P Bartholoma","year":"2002","unstructured":"Bartholoma P, Erlandsson N, Kaufmann K, et al.: Neuronal cell death induced by antidepressants: lack of correlation with Egr-1, NF-kappa B, and extracellular signal-regulated protein kinase activation. Biochem Pharmacol 2002, 63:1507\u20131516.","journal-title":"Biochem Pharmacol"},{"key":"6_CR40","first-page":"21","volume":"26","author":"J Sawynok","year":"2001","unstructured":"Sawynok J, Esser MJ, Reid AR: Antidepressants as analgesics: an overview of central and peripheral mechanisms of action. J Psychiatry Neurosci 2001, 26:21\u201329. An updated overview of antidepressants.","journal-title":"J Psychiatry Neurosci"},{"key":"6_CR41","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1345\/aph.18431","volume":"33","author":"JD Joss","year":"1999","unstructured":"Joss JD: Tricyclic antidepressant use in diabetic neuropathy. Ann Pharmacother 1999, 33:996\u20131000. Review of the most common neuropathic pain complaints.","journal-title":"Ann Pharmacother"},{"key":"6_CR42","doi-asserted-by":"publisher","first-page":"737","DOI":"10.2165\/00002512-200118100-00003","volume":"18","author":"PG Jensen","year":"2001","unstructured":"Jensen PG, Larson JR: Management of painful diabetic neuropathy. Drugs Aging 2001, 18:737\u201349. Emphasis on managing elder patients with special therapeutic considerations.","journal-title":"Drugs Aging"},{"issue":"suppl 1","key":"6_CR43","first-page":"380A","volume":"15","author":"SH Sindrup","year":"1993","unstructured":"Sindrup SH, Brosen K, Gran LF: The mechanism of action of antidepressants in pain treatment: controlled cross-over studies in diabetic neuropathy. Clin Neuropharmacol 1993, 15(suppl 1):380A-381A.","journal-title":"Clin Neuropharmacol"},{"key":"6_CR44","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/00002508-199712000-00009","volume":"13","author":"M Vrethem","year":"1997","unstructured":"Vrethem M, Boivie J, Arnqvist H, et al.: A comparison a amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics. Clin J Pain 1997, 13:313\u2013323.","journal-title":"Clin J Pain"},{"key":"6_CR45","first-page":"111","volume":"12","author":"R Biesbroeck","year":"1995","unstructured":"Biesbroeck R, Bril V, Hollander P, et al.: A double-blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy. Adv Ther 1995, 12:111\u2013120.","journal-title":"Adv Ther"},{"key":"6_CR46","first-page":"17","volume":"3","author":"JR Satterthwaite","year":"1990","unstructured":"Satterthwaite JR: Acute herpes zoster: diagnosis and treatment. Pain Manage 1990, 3:17\u201328.","journal-title":"Pain Manage"},{"key":"6_CR47","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/ana.410200602","volume":"20","author":"RK Portenoy","year":"1986","unstructured":"Portenoy RK, Duma C, Foley KM: Acute herpetic and postherpetic neuralgia: clinical review and current management. Ann Neurol 1986, 20:651\u2013664.","journal-title":"Ann Neurol"},{"key":"6_CR48","unstructured":"Loeser JD: Postherpetic neuralgia: a review of pathophysiology and treatment. Presented at the Annual Meeting of the American Pain Society. Washington, DC; November 8, 1986."},{"key":"6_CR49","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1016\/0304-3959(85)90009-0","volume":"23","author":"CPN Watson","year":"1985","unstructured":"Watson CPN, Evans RJ: A comparative trial of amitriptyline and zimeldine in postherpetic neuralgia. Pain 1985, 23:3887\u20133894.","journal-title":"Pain"},{"key":"6_CR50","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0304-3959(92)90128-X","volume":"48","author":"CP Watson","year":"1992","unstructured":"Watson CP, Chipman M, Reed K, et al.: Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial. Pain 1992, 48:29\u201336.","journal-title":"Pain"},{"key":"6_CR51","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.2165\/00003495-200059050-00007","volume":"59","author":"GE Kanazi","year":"2000","unstructured":"Kanazi GE, Johnson RW, Dworkin RH: Treatment of postherpetic neuralgia: an update. Drugs 2000, 59:1113\u20131126.","journal-title":"Drugs"},{"key":"6_CR52","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1212\/WNL.51.4.1166","volume":"51","author":"CP Watson","year":"1998","unstructured":"Watson CP, Vernich L, Chipman M, Reed K: Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology 1998, 51:1166\u20131171.","journal-title":"Neurology"},{"key":"6_CR53","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0304-3959(01)00483-3","volume":"96","author":"DD Cardenas","year":"2002","unstructured":"Cardenas DD, Warms CA, Turner JA, et al.: Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a randomized controlled trial. Pain 2002, 96:365\u2013373.","journal-title":"Pain"},{"key":"6_CR54","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0025-6196(11)62332-X","volume":"77","author":"RH Rho","year":"2002","unstructured":"Rho RH, Brewer RP, Lamer TJ, Wilson PR: Complex regional pain syndrome. Mayo Clin Proc 2002, 77:174\u2013180.","journal-title":"Mayo Clin Proc"},{"key":"6_CR55","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0304-3959(90)91157-E","volume":"42","author":"SH Sindrup","year":"1990","unstructured":"Sindrup SH, Gram LF, Br\u00f8sen K, et al.: The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy syndromes. Pain 1990, 42:135\u2013145.","journal-title":"Pain"},{"key":"6_CR56","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1345\/aph.10206","volume":"35","author":"JE Sumpton","year":"2001","unstructured":"Sumpton JE, Moulin DE: Treatment of neuropathic pain with venlafaxine. Ann Pharmacother 2001, 35:557\u2013559. A look at a newer non-tricyclic antidepressant that may share common mechanistic properties with its predecessors.","journal-title":"Ann Pharmacother"},{"key":"6_CR57","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1067\/mcp.2001.114873","volume":"69","author":"TP Enggaard","year":"2001","unstructured":"Enggaard TP, Klitgaard NA, Gram LF, et al.: Specific effect of venlafaxine on single and repetitive experimental painful stimuli in humans. Clin Pharmacol Ther 2001, 69:245\u2013251.","journal-title":"Clin Pharmacol Ther"},{"key":"6_CR58","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0304-3959(96)03223-X","volume":"68","author":"E Lang","year":"1996","unstructured":"Lang E, Hord AH, Denson D: Venlafaxine hydrochloride (Effexor) relieves thermal hyperalgesia in rats with an experimental mononeuropathy. Pain 1996, 68:151\u2013155.","journal-title":"Pain"},{"key":"6_CR59","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1212\/WNL.57.9.1583","volume":"57","author":"MR Semenchuk","year":"2001","unstructured":"Semenchuk MR, Sherman S, Davis B: Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain. Neurology 2001, 57:1583\u20131588.","journal-title":"Neurology"},{"key":"6_CR60","first-page":"105","volume":"68","author":"C Mattia","year":"2002","unstructured":"Mattia C, Paoletti F, Coluzzi F, Boanelli A: New antidepressants in the treatment of neuropathic pain: a review. Minerva Anestesiol 2002, 68:105\u2013114. Offers a thorough overview of the newer atypical agents in managing painful neuropathies.","journal-title":"Minerva Anestesiol"},{"key":"6_CR61","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1001\/jama.268.24.3441","volume":"268","author":"S Kapur","year":"1992","unstructured":"Kapur S, Mieczkowski T, Mann J: Antidepressant medications and the relative risk of suicide attempt and suicide. JAMA 1992, 268:3441\u20133345.","journal-title":"JAMA"},{"key":"6_CR62","doi-asserted-by":"publisher","first-page":"730","DOI":"10.2165\/00003495-199142050-00002","volume":"42","author":"G Magi","year":"1991","unstructured":"Magi G: The use of antidepressants in the treatment of chronic pain. Drugs 1991, 42:730\u2013748.","journal-title":"Drugs"},{"key":"6_CR63","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0885-3924(00)00218-9","volume":"20","author":"SL Collins","year":"2000","unstructured":"Collins SL, Moore RA, McQuay HJ, Wiffen P: Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review. J Pain Symptom Manage 2000, 20:449\u2013458. Provides evidenced-based support for the use of antidepressants in the most common types of neuropathic pain.","journal-title":"J Pain Symptom Manage"},{"key":"6_CR64","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1097\/00000539-200204000-00037","volume":"94","author":"CE Heughan","year":"2002","unstructured":"Heughan CE, Sawynok J: The interaction between gabapentin and amitriptyline in the rat formalin test after systemic administration. Anesth Analg 2002, 94:975\u2013980.","journal-title":"Anesth Analg"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-003-0006-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-003-0006-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-003-0006-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-003-0006-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T01:41:34Z","timestamp":1737078094000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-003-0006-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["6"],"URL":"https:\/\/doi.org\/10.1007\/s11916-003-0006-4","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2]]}}}